SEC Form 4 · accession 0001127602-15-000758
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Troyen A Brennan
Officer — EVP, Chief Medical Officer
Period of report
Jan 2, 2015
Accepted (ET)
Jan 5, 2015 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 2, 2015 | M | 50,240 | $34.96 | A | 91,487 | D | |
| Common StockF2 | Jan 2, 2015 | S | 50,240 | $95.7109 | D | 41,247 | D | |
| Common Stock (restricted) | holding | — | — | — | 49,991 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF3 | $34.96 | Jan 2, 2015 | M | 50,240 | D | Apr 1, 2012 | Apr 1, 2018 | Common Stock | 50,240 | 16,747 | D |
| Stock OptionF4 | $45.07 | holding | — | — | — | Apr 2, 2013 | Apr 2, 2019 | Common Stock | 66,548 | 66,548 | D |
| Stock OptionF5 | $54.53 | holding | — | — | — | Apr 1, 2014 | Apr 1, 2020 | Common Stock | 47,207 | 47,207 | D |
| Stock OptionF6 | $74.29 | holding | — | — | — | Apr 1, 2015 | Apr 1, 2021 | Common Stock | 54,550 | 54,550 | D |
Explanation of responses
- F1All sales were effected pursuant to a Rule 10b5-1 plan.
- F2Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $94.40 and $96.85 per share.
- F3Option became exercisable in four equal annual installments, commencing 4/1/2012.
- F4Option became exercisable in four equal annual installments, commencing 4/2/2013.
- F5Option became exercisable in four equal annual installments, commencing 4/1/2014.
- F6Option becomes exercisable in four equal annual installments, commencing 4/1/2015.